Alnylam Pharmaceuticals
ALNY
#584
Rank
C$49.09 B
Marketcap
$379.30
Share price
4.33%
Change (1 day)
85.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $427.23 CAD on 2024-10-16

Lowest end of day price: $5.61 CAD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$18.04 3.97%๐Ÿ‡บ๐Ÿ‡ธ USA
$889.29 1.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$88.80 0.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.35-0.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.79 12.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$157.46 1.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$76.69-0.72%๐Ÿ‡ซ๐Ÿ‡ท France
$21.73 0.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel